Vascular Access and Closure Devices
Terumo’s portfolio offers a full range of access and closure solutions uniquely engineered to achieve the best possible outcomes.
Terumo Access Devices
Radial Access
Glidesheath Slender®
The #1 preferred radial access sheath on the global market*
Glidesheath Slender has a unique, thin wall design combined with a hydrophilic coating, and featuring a low-profile sheath to reduce arteriotomy size.1,2,3 This enables transradial access without compromise.
Learn more about this hydrophilic-coated introducer sheath.
*Data on File
Femoral Access
Pinnacle® Precision
Pinnacle Precision Access System provides smooth, atraumatic access, which has been proven to help reduce complications and enable same-day discharge.4 Total Integrated Fit Technology (TIF) allows for seamless sheath transition which minimizes trauma and supports uncomplicated closing.5
Tibial Pedal Access
Glidesheath Slender Tibial Pedal Access Kit
Rethink sizing and expand your options for procedural success with Glidesheath Slender’s Tibial Pedal Kit.
Learn more about the proprietary technology in this tibial access kit.
Terumo Closure Devices
Radial Closure
TR Band®
The #1 preferred radial hemostasis device on the global market*
TR Band provides precise compression to achieve radial hemostasis at low pressures, minimizing the chances of applying occlusive force6. With dual balloon technology providing precise compression of the radial artery without compromising local nerve structure.
Learn more about TR Band radial approach to hemostasis.
*Data on file.
Femoral Closure
Angio Seal Vascular Closure Device
The #1 vascular closure device on the global market*
Angio Seal provides active closure for rapid and reliable hemostasis proven to accelerate patient mobility and enable same day discharge. Resorbable components provide immediate closure with uncompromised blood flow 7,8,9
*Data on file.
Ref:
1. Saito S, et al. Influence of the ratio between radial artery inner diameter and sheath outer diameter on radial artery flow after transradial coronary intervention. Cath Cardio Interv. 1999;46:173-178. 2. Pancholy S. Prevention of radial artery occlusion—patent hemostasis evaluation trial (PROPHET Study): A randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Cath Cardio Interv. 2008;72:335-340. 3. Dahm J, et al. A Randomized Trial of 5 vs. 6 French Transradial Percutaneous Coronary Interventions. Cath Cardio Interv. 2002;57:172–176. 4. Data on file. Terumo Medical Corporation. TIF Engineering Evaluation and Test Production Results #20070045. 5. Data on file. Terumo Medical Corporation. Pinnacle Precision Access System Competitor Evaluation Report #20170018. 6. Ono K. Experience of the TR BAND for the Diagnostic Catheter Procedure. Yuri Union General Hospital in Akita Pref., September 2004. 7. Kapadia SR, Raymond R, Knopf W, et al. Am J Cardiol. 2001;87:789-791. 8. Nash JE, Evans DG. Herz. 1999;24(8):597-606. http://dx.doi.org/10.1007/bf03044483. 9. Angio-Seal™ STS Plus, Angio-Seal™ VIP and Angio-Seal™ Evolution Instructions for Use.
DOCUMENTS
REFERENCES
RX ONLY. Refer to the product labels and package insert for complete warnings, precautions, potential complications, and instructions for use.